Genomic & Biopharma NewsFDA slaps new bladder cancer limits on Merck's Keytruda, Roche's Tecentriq
Last month, the FDA warned that immuno-oncology stars from Merck and Roche might actually be hurting some previously untreated bladder cancer patients’ survival chances. And now, it’s followed up by narrowing the drugs’ labels.
|Fierce Pharma, 2018-06-22 15:33:40|
Identification and analysis of ribosome-associated lncRNAs using ribosome profiling data
Although the number of discovered long non-coding RNAs (lncRNAs) has increased dramatically, their biological roles have not been established. Many recent studies have used ribosome profiling data to assess the protein-coding capacity of lncRNAs...
|lncRNA Research and Industry News, 2018-06-22 15:09:23|
Electronic Sun Sentinel: Gene analysis lab moves to Deerfield Beach
|ORB Company News, 2016-12-02 21:24:27|
Webinar Recording Available – Achieve high-throughput 3′ transcriptome RNA-seq with 1 ng samples
Gene expression analysis using next-generation sequencing (NGS) has advantages in throughput, sensitivity and accuracy over qPCR and microarray methods. However, current limitations with library...
|Transcriptome Research & Industry News, 2018-06-22 14:57:04|
Sun Sentinel: Ocean Ridge Biosciences expands to 5,400-square foot facility
Ocean Ridge Biosciences is a survivor in South Florida's fledgling biotech industry. In the past decade, Ocean Ridge has worked with more than 200 academic labs and companies, providing gene-based lab analysis of blood and tissue samples for the development of new drugs and diagnostic tests. Please read the PDF for more details
|ORB Company News, 2016-12-28 18:58:47|
FDA accepts Bristol-Myers' Opdivo-Yervoy app in lung cancer, but without a speedy review
Bristol-Myers Squibb’s Opdivo is finally under FDA consideration as a therapy for previously untreated lung cancer, but it will still be a while before it can compete in the key market.
|Fierce Pharma, 2018-06-22 14:50:13|
James Sabry takes over global partnering for Roche
Roche has taken care to keep its pharma R&D group distinct from Genentech's since it acquired the biotech in 2008. In a reversal, the company is combining their partnering operations.
|Fierce Biotech, 2018-06-22 14:16:49|
NICE reconsiders and agrees to back Roche’s Ocrevus in relapsing multiple sclerosis—with strings attached
About two months after England’s cost watchdog decided Roche’s multiple sclerosis star Ocrevus wasn’t cost-effective enough to win reimbursement backing in relapsing forms of the disease, the agency overturned that ruling with one limitation.
|Fierce Pharma, 2018-06-22 13:59:28|
Shire wins FDA approval to make Gammagard Liquid at new U.S. plant, ramps up hiring
Shire has won approval to transfer production of an important replacement therapy to a plant in Georgia that it got in its 2016 buyout of Baxalta.
|Fierce Pharma, 2018-06-22 13:57:16|
LSTM led consortium receives grant to investigate how human behavior impacts AMR
An LSTM led consortium called DRUM has been awarded £3 million to investigate the way in which human behaviour drives the emergence and spread of antimicrobial resistance
|News Medical Life Sciences, 2018-06-22 13:55:35|
Are you the best at what you do?
Designed to assess and reward the competencies and potential of pharma marketers and teams, the PharmaTimes Marketer of the Year competition identifies and benchmarks marketing talent within pharma organisations.
|PharmaTimes, 2018-06-22 13:55:10|